Found: 3
Select item for more details and to access through your institution.
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1789, doi. 10.1111/all.14670
- By:
- Publication type:
- Article
Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study.
- Published in:
- Clinical & Translational Allergy, 2021, v. 11, n. 4, p. 1, doi. 10.1002/clt2.12035
- By:
- Publication type:
- Article
Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 4, p. 1027, doi. 10.1111/cts.13233
- By:
- Publication type:
- Article